Avalon BioVentures I, LP, 10% Owner at Janux Therapeutics, Inc. (JANX), sold 244,364 shares at $42.33 ($10.3M) on 2024-09-09, disclosed to the SEC on 2024-09-10.
Open-market sale of $10.3M JANX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.00 | 20,991 | $882K | 8.6% |
| 2 | $42.00 | 108,365 | $4.6M | 44.3% |
| 3 | $42.00 | 110,644 | $4.6M | 45.3% |
| 4 | $42.33 | 2,182 | $92K | 0.9% |
| 5 | $42.33 | 2,182 | $92K | 0.9% |
| Total | $42.01 avg | 244,364 |
| $10.3M |
| 100% |
| Filing → |